Arkolith/Insider Trading/XERS/Form 4

McCulloch Kevin

See RemarksXeris Biopharma Holdings, Inc. (XERS) · full profile →Form 4 · filed Jun 16, 2025
Net Buying
Open-Market Buys
$110K
Open-Market Sells
$0
Net Open-Market Flow
$110K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jun 13, 2025Buy(P)25K$4.38$110K1.7M

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001867096-25-000118) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML